Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus

Alemtuzumab (Lemtrada(®)) is a humanized monoclonal antibody indicated for the treatment of adult patients with relapsing–remitting multiple sclerosis with active disease defined by clinical or imaging features. Alemtuzumab demonstrated superior efficacy over active comparator in both treatment naiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Lambert, Catherine, Dubois, Benedicte, Dive, Dominique, Lysandropoulos, Andreas, Selleslag, Dominik, Vanopdenbosch, Ludo, Van Pesch, Vincent, Vanwijmeersch, Bart, Janssens, Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Consensus paper and Guideline
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857274/
https://www.ncbi.nlm.nih.gov/pubmed/29380254
http://dx.doi.org/10.1007/s13760-018-0882-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857274/
https://www.ncbi.nlm.nih.gov/pubmed/29380254
http://dx.doi.org/10.1007/s13760-018-0882-3

Ejemplares similares